This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office] .
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
United States Code U.S. Code: Title 49 - TRANSPORTATION
Title 49 published on 09-Jun-2018 04:52
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 49 CFR Part 40 after this date.
2017-11-13; vol. 82 # 217 - Monday, November 13, 2017 82 FR 52229 - Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Certain Schedule II Drugs to the Department of Transportation's Drug-Testing Panel and Certain Minor Amendments
GPO FDSys XML | Text Additional Documents DEPARTMENT OF TRANSPORTATION, Office of the Secretary Final rule. This rule is effective on January 1, 2018. 49 CFR Part 40 Summary The Department of Transportation is amending its drug-testing program regulation to add hydrocodone, hydromorphone, oxymorphone, and oxycodone to its drug-testing panel; add methylenedioxyamphetamine as an initial test analyte; and remove methylenedioxyethylamphetamine as a confirmatory test analyte. The revision of the drug-testing panel harmonizes DOT regulations with the revised HHS Mandatory Guidelines established by the U.S. Department of Health and Human Services for Federal drug-testing programs for urine testing. This final rule clarifies certain existing drug-testing program provisions and definitions, makes technical amendments, and removes the requirement for employers and Consortium/Third Party Administrators to submit blind specimens.
2017-01-23; vol. 82 # 13 - Monday, January 23, 2017 82 FR 7771 - Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Certain Schedule II Drugs to the Department of Transportation's Drug-Testing Panel and Certain Minor Amendments
GPO FDSys XML | Text Additional Documents DEPARTMENT OF TRANSPORTATION, Office of the Secretary Notice of proposed rulemaking. Comments to the notice of proposed rulemaking should be submitted by March 24, 2017. Late-filed comments will be considered to the extent practicable. 49 CFR Part 40 Summary The Department of Transportation is proposing to amend its drug-testing program regulation to add four opioids (hydrocodone, hydromorphone, oxymorphone, and oxycodone) to its drug-testing panel; add methylenedioxyamphetamine (MDA) as an initial test analyte; and remove methylenedioxyethylamphetamine, (MDEA) as a confirmatory test analyte. The proposed revision of the drug-testing panel is intended to harmonize with the revised Mandatory Guidelines established by the U.S. Department of Health and Human Services for Federal drug-testing programs for urine testing. This proposal also adds clarification to certain drug-testing program provisions where necessary, removes outdated information in the regulations that is no longer needed, and proposes to remove the requirement for employers and Consortium/Third Party Administrators to submit blind specimens.
2016-08-08; vol. 81 # 152 - Monday, August 8, 2016 81 FR 52364 - Technical Amendment
GPO FDSys XML | Text Additional Documents DEPARTMENT OF TRANSPORTATION, Office of the Secretary Final rule. This final rule is effective on August 8, 2016. 49 CFR Part 40 Summary This final rule amends the U.S. Department of Transportation's (DOT) regulation to conform to recent legislation that changed the definition of the term “service agent” in the DOT drug and alcohol testing regulations. The final rule also revises the definition of “service agent” to include all entities that provide services for DOT mandated drug and alcohol programs.
2015-04-13; vol. 80 # 70 - Monday, April 13, 2015 80 FR 19551 - Use of Electronic Chain of Custody and Control Form in DOT-Regulated Drug Testing Programs
GPO FDSys XML | Text Additional Documents DEPARTMENT OF TRANSPORTATION, Office of the Secretary Final rule. This final rule is effective on April 13, 2015. 49 CFR Part 40 Summary This action amends the U.S. Department of Transportation's (DOT) regulations to incorporate changes to the Substance Abuse and Mental Health Services Administration's (SAMHSA) chain of custody and control form (CCF) recently approved by the Office of Management and Budget (OMB). Specifically, this rulemaking expands the DOT's definition of the CCF to include both paper and electronic forms.
2012-10-03; vol. 77 # 192 - Wednesday, October 3, 2012 77 FR 60318 - Procedures for Transportation Workplace Drug and Alcohol Testing Programs: 6-acetylmorphine (6-AM) Testing
GPO FDSys XML | Text Additional Documents DEPARTMENT OF TRANSPORTATION, Office of the Secretary Final rule. The rule is effective October 3, 2012. 49 CFR Part 40 Summary This rule adopts as final, without change, a May 4, 2012, interim final rule (IFR) which no longer requires laboratories and Medical Review Officers (MRO) to consult with one another regarding the testing for the presence of morphine when the laboratory confirms the presence of 6-acetylmorphine (6-AM). Also, laboratories and MROs will no longer need to report 6-AM results to the Office of Drug and Alcohol Policy and Compliance (ODAPC). This rule also responds to comments on the IFR.
2012-05-04; vol. 77 # 87 - Friday, May 4, 2012 77 FR 26471 - Procedures for Transportation Workplace Drug and Alcohol Testing Programs: 6-acetylmorphine (6-AM) Testing
GPO FDSys XML | Text Additional Documents DEPARTMENT OF TRANSPORTATION, Office of the Secretary Interim final rule. The rule is effective July 3, 2012. Comments to this interim final rule should be submitted by June 4, 2012. Late-filed comments will be considered to the extent practicable. 49 CFR Part 40 Summary The Department is amending certain provisions of its drug testing procedures for 6-acetylmorphine (6-AM), a unique metabolite of heroin. Laboratories and Medical Review Officers (MROs) will no longer be required to consult with one another regarding the testing for the presence of morphine when the laboratory confirms the presence of 6-AM. This rule is intended to streamline the laboratory process for analyzing and reporting 6-AM positive results and will facilitate MRO verification of 6-AM positive results.
